Is Abbott Laboratories Attractively Priced After Recent Share Price Gains And DCF Concerns? [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
Despite slipping about 2.5% over the last week and 2.3% over the past month, Abbott is still up 10.4% year to date and roughly 11.6% over the last year, which keeps it firmly on investors radar as a steady compounder. Recent attention on Abbott has centered on its medical devices and diagnostics businesses, including ongoing innovation in areas like glucose monitoring and cardiovascular devices that support its long term growth story. At the same time, regulatory updates and product cycle headlines have reminded the market that even high quality healthcare names can see sentiment swing as expectations reset. On our checklist of six valuation tests, Abbott scores a 3 out of 6 , suggesting it is neither a screaming bargain nor wildly overpriced. In the next sections we will dig into what the DCF, multiples, and other methods say, before finishing with a more intuitive way to think about its true value. Abbott Laboratories delivered 11.6% returns over the last year. See how this s
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial Fibrillation [Yahoo! Finance]Yahoo! Finance
- Abbott's Volt™ Pulsed Field Ablation System Receives FDA Approval to Treat Patients with Atrial FibrillationPR Newswire
- Investors in Abbott Laboratories (NYSE:ABT) have seen returns of 27% over the past five years [Yahoo! Finance]Yahoo! Finance
- What Abbott Laboratories (ABT)'s New Pediatric Heart Device Clearances Mean For Shareholders [Yahoo! Finance]Yahoo! Finance
- ??????????? ???????? - ??????????????????2026-2035? [CNET News]CNET News
ABT
Earnings
- 10/15/25 - In-Line
ABT
Sec Filings
- 12/19/25 - Form 3
- 12/12/25 - Form 4
- 12/12/25 - Form 8-K
- ABT's page on the SEC website